Derric Wood Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Derric Wood Pharmaceutical Export Portfolio Dataset — 7 Products, $793.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Derric Wood — Pharmaceutical Exporter Profile (2026) | 7 Products, $793.8K Trade | TransData Nexus

Derric Wood

Indian Pharmaceutical Exporter · Antimalarial & Antiparasitic Specialist · $793.8K Total Trade · DGFT Verified

Derric Wood is an Indian pharmaceutical exporter with a total trade value of $793.8K across 7 products in 5 therapeutic categories. Based on 6,514 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ivermectin ($229.2K), Valacyclovir ($199.4K), Hydroxychloroquine ($199.1K).

Derric Wood — Export Portfolio & Destination Treemap

Derric Wood pharmaceutical export portfolio — 7 products across 5 therapeutic categories. Source: Indian Customs (DGFT).

Who is Derric Wood? — Company Overview & Market Position

Derric Wood is a prominent Indian pharmaceutical exporter specializing in the wholesale distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2000, the company is headquartered in New Delhi, India, at Unit No. 702-704, Gopal Heights, Netaji Subhash Place Complex, Pitampura. Derric Wood operates as a privately held entity, with ownership details not publicly disclosed. The company has reported an annual turnover between 51 to 100 crores INR, indicating a substantial presence in the pharmaceutical export sector. While specific employee count figures are not publicly available, the company's extensive operations suggest a sizable workforce. Derric Wood's official website, derricwood.com, provides comprehensive information about its products and services.

What Does Derric Wood Export? — Product Portfolio Analysis

Top Products by Export Value

1Ivermectin$229.2K 2Valacyclovir$199.4K

Product Portfolio — Top 7 by Export Value

Derric Wood exports 7 pharmaceutical products across 5 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ivermectin	Antimalarial & Antiparasitic	$229.2K	2,314	2.6%	9
2	Valacyclovir	Antivirals	$199.4K	972	0.2%	11
3	Hydroxychloroquine	Antimalarial & Antiparasitic	$199.1K	965	0.1%	9
4	Sirolimus	Immunosuppressants	$89.2K	675	0.6%	10
5	Tiotropium	Respiratory	$50.7K	978	0.1%	9
6	Acarbose	Advanced Diabetes Medications	$18.8K	510	0.3%	9
7	Canagliflozin	Advanced Diabetes Medications	$7.3K	100	0.8%	9

Derric Wood exports 7 pharmaceutical products across 5 therapeutic categories with a total export value of $793.8K. The top category is Antimalarial & Antiparasitic (54.0% of portfolio), followed by Antivirals (25.1%), indicating a concentrated portfolio with the top 5 products accounting for 96.7% of total export value.

Derric Wood — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Derric Wood sources its pharmaceutical products from leading Indian manufacturers, including Cipla, Sun Pharma, Ranbaxy, Intas Pharma, Ajanta Pharma, Cadila, Dr. Reddy's, Lupin, Biotech, and Himalaya. The company does not operate its own manufacturing facilities but collaborates closely with these manufacturers to ensure product quality and compliance with international standards. By leveraging the capabilities of established pharmaceutical companies, Derric Wood can offer a diverse range of high-quality products to its global clientele.

3Key Leadership

Specific details regarding the CEO, CFO, and other key executives of Derric Wood are not publicly disclosed. The company's leadership structure remains private, and information about individual roles and responsibilities is not readily available. This lack of publicly accessible information may be due to the company's private ownership and limited public reporting.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Derric Wood Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Derric Wood's export activities are primarily focused on markets in Switzerland, Singapore, and the Czech Republic. The company has completed 305,553 export shipments to 23 verified buyers across these regions, indicating a strong presence in these markets. While specific regulatory filings and approvals in the United States, European Union, United Kingdom, Australia, and Japan are not publicly detailed, the company's extensive export activities suggest compliance with international regulatory standards. Derric Wood's partnerships with reputable Indian pharmaceutical manufacturers, many of which hold approvals from agencies such as the US FDA, MHRA (UK), and TGA (Australia), further support the company's adherence to global regulatory requirements.

2Emerging Markets

Derric Wood's export data indicates a significant presence in emerging markets, particularly in Africa, Latin America, and Southeast Asia. The company's extensive export activities to regions such as Switzerland, Singapore, and the Czech Republic suggest a strategic focus on expanding its footprint in these markets. While specific details regarding WHO prequalification are not publicly available, the company's collaborations with leading Indian pharmaceutical manufacturers, many of which hold approvals from international regulatory bodies, suggest a commitment to meeting global quality standards.

Geographic Strategy

Derric Wood — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Derric Wood's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's export data does not provide insights into its interactions with the U.S. Food and Drug Administration. This lack of publicly accessible information may be due to the company's private ownership and limited public reporting.

2WHO & EU GMP

Derric Wood's collaborations with leading Indian pharmaceutical manufacturers, many of which hold approvals from international regulatory bodies such as the World Health Organization (WHO) and the European Union's Good Manufacturing Practice (EU GMP) standards, suggest a commitment to meeting global quality standards. However, specific details regarding Derric Wood's own certifications or approvals from these organizations are not publicly available. The company's focus on sourcing products from reputable manufacturers indicates adherence to international quality norms.

3CDSCO & Indian Regulatory

Derric Wood — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Derric Wood operates in a competitive landscape with numerous pharmaceutical exporters in India. Companies such as Cipla, Sun Pharma, Ranbaxy, Intas Pharma, Ajanta Pharma, Cadila, Dr. Reddy's, Lupin, Biotech, and Himalaya are significant players in the Indian pharmaceutical export sector. While Derric Wood's export data indicates a substantial number of shipments, specific market share comparisons and head-to-head analyses with these competitors are not publicly available. The company's focus on sourcing products from leading manufacturers and its extensive export activities suggest a competitive positioning in the market.

2Key Differentiators

Derric Wood's key differentiators include its extensive range of pharmaceutical and herbal formulations, including ayurvedic preparations, cosmetics, and herbal remedies. The company's collaborations with leading Indian pharmaceutical manufacturers, many of which hold approvals from international regulatory bodies, ensure product quality and compliance with global standards. Derric Wood's commitment to customer confidentiality and its focus on providing a unique shopping experience further distinguish it in the market.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Derric Wood as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Derric Wood has a substantial track record in the pharmaceutical export sector, with 305,553 export shipments to 23 verified buyers across key markets, including Switzerland, Singapore, and the Czech Republic. The company's collaborations with leading Indian pharmaceutical manufacturers, many of which hold approvals from international regulatory bodies such as the US FDA, MHRA (UK), and TGA (Australia), suggest a reliable and consistent supply chain. Derric Wood's focus on customer confidentiality and its commitment to providing a unique shopping experience further enhance its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering products from Derric Wood:

FDA Approval: Confirm that the products are approved by the U.S. Food and Drug Administration (FDA). This can be verified through the FDA's official website or by requesting certification documents from Derric Wood.

WHO-GMP Certification: Ensure that the products are manufactured in facilities certified by the World Health Organization's Good Manufacturing Practice (WHO-GMP). This can be verified by checking the WHO's official website or by requesting certification documents from Derric Wood.

Frequently Asked Questions — Derric Wood

How many pharmaceutical products does Derric Wood export from India?

Derric Wood exports 7 pharmaceutical products across 5 therapeutic categories. The top exports are Ivermectin ($229.2K), Valacyclovir ($199.4K), Hydroxychloroquine ($199.1K), Sirolimus ($89.2K), Tiotropium ($50.7K). Total export value is $793.8K.

What is Derric Wood's total pharmaceutical export value?

Derric Wood's total pharmaceutical export value is $793.8K, based on 6,514 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Derric Wood cover?

Derric Wood exports across 5 therapeutic categories. The largest are Antimalarial & Antiparasitic (54.0%, 2 products), Antivirals (25.1%, 1 products), Immunosuppressants (11.2%, 1 products).

Get Full Derric Wood Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.